Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Spillantini

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Parkinsonism & Related Disorders|July 2, 2008
Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathiesM G Spillantini
Pharmacology, Biochemistry, and Behavior|May 1, 1986
Inhibition of penicillin-induced EEG discharges by low doses of morphine or naloxone in the rabbit. Evidence for a possible non-opioid receptor-mediated mechanism at the sensorimotor cortexM G Spillantini, M Massotti
Biochimica Et Biophysica Acta|July 19, 2000
Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's diseaseM Goedert, M G Spillantini
Cellular and Molecular Neurobiology|March 1, 1990
Molecular neuropathology of Alzheimer's disease: in situ hybridization studiesM Goedert, M G Spillantini
Trends in Neurosciences|October 24, 1998
Tau protein pathology in neurodegenerative diseasesM G Spillantini, M Goedert
JAMA|November 17, 2001
Tau and Parkinson diseaseM G Spillantini, M Goedert
Biochemical Society Symposium|July 13, 2001
Tau gene mutations and neurodegenerationM Goedert, M G Spillantini
Molecular Psychiatry|December 19, 1998
Lewy body diseases and multiple system atrophy as alpha-synucleinopathiesM Goedert, M G Spillantini
Annals of the New York Academy of Sciences|February 24, 2001
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophyM G Spillantini, M Goedert
Neuropathology and Applied Neurobiology|January 29, 2016
Synucleinopathies: past, present and futureM G Spillantini, M Goedert
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Parkinsonism & Related Disorders|July 2, 2008
Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathiesM G Spillantini
Pharmacology, Biochemistry, and Behavior|May 1, 1986
Inhibition of penicillin-induced EEG discharges by low doses of morphine or naloxone in the rabbit. Evidence for a possible non-opioid receptor-mediated mechanism at the sensorimotor cortexM G Spillantini, M Massotti
Biochimica Et Biophysica Acta|July 19, 2000
Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's diseaseM Goedert, M G Spillantini
Cellular and Molecular Neurobiology|March 1, 1990
Molecular neuropathology of Alzheimer's disease: in situ hybridization studiesM Goedert, M G Spillantini
Trends in Neurosciences|October 24, 1998
Tau protein pathology in neurodegenerative diseasesM G Spillantini, M Goedert
JAMA|November 17, 2001
Tau and Parkinson diseaseM G Spillantini, M Goedert
Biochemical Society Symposium|July 13, 2001
Tau gene mutations and neurodegenerationM Goedert, M G Spillantini
Molecular Psychiatry|December 19, 1998
Lewy body diseases and multiple system atrophy as alpha-synucleinopathiesM Goedert, M G Spillantini
Annals of the New York Academy of Sciences|February 24, 2001
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophyM G Spillantini, M Goedert
Neuropathology and Applied Neurobiology|January 29, 2016
Synucleinopathies: past, present and futureM G Spillantini, M Goedert
Pageof 11